Ipamix

Quick links to important sections

Ipamix

Treatment option: Hypertension

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Ipamix

What is Ipamix? Defining its Nature and Action

Property Description
Active Ingredient Indapamide
Form Oral Tablet (Film-Coated)
Pharmacological Class Thiazide-like Diuretic, Antihypertensive Agent
Common Use Help lower blood pressure
Origin Synthetic Compound (Sulfonamide Derivative)

Ipamix is a pharmaceutical preparation that contains the single active substance, Indapamide. It is chemically classified as a synthetic compound derived from the sulfonamide chemical group and is designed exclusively for oral administration. Pharmacologically, it is an antihypertensive agent and specifically a thiazide-like diuretic, used primarily to manage issues related to pressure and fluid balance in the circulatory system.

Indapamide: Composition and Unique Identity

The key component of Ipamix is Indapamide hemihydrate. As a single-ingredient medication, its composition focuses entirely on the established action of the Indapamide compound. Indapamide is often distinguished from classic thiazide diuretics due to its unique indoline chemical structure, which contributes to its "thiazide-like" classification. This structural difference is associated with a dual action on both the kidneys and the blood vessels.

General Purpose: How Ipamix Helps Achieve Pressure Balance

The general purpose of Ipamix is to help lower blood pressure by influencing both the body's fluid levels and the resistance in blood vessels. This dual physiological action is achieved by two primary principles: enhancing salt and water excretion from the kidneys (the diuretic effect) and relaxing blood vessel walls (the vascular action). Indapamide is recognized for its role in sustained blood pressure reduction, which means the medication helps the body achieve and maintain healthier, reduced pressure levels in the circulatory system.

What side effects are possible with Ipamix?

Possible side effects and safety information

The official safety profile for Ipamix, containing Indapamide, classifies possible adverse reactions by frequency and the body system affected, based on regulatory documentation.


Frequency and Systemic Classification

The most frequent adverse reactions involve Metabolism and nutrition disorders. The most Common reaction documented is hypokalemia (low blood potassium). Reactions like hyponatraemia (low blood sodium) and vomiting are categorized as Uncommon. Rare effects include headache, dizziness, and gastrointestinal disturbances such as constipation and dry mouth. Adverse effects are also documented within Skin and subcutaneous tissue disorders, ranging from common rashes to very rare, severe reactions.


Clinically Significant and Serious Reactions

The regulatory profile identifies certain rare events as clinically significant. Very Rare classifications include severe blood disorders like aplastic anaemia and life-threatening skin conditions, specifically Stevens-Johnson Syndrome (SJS) and Toxic Epidermal Necrolysis (TEN). The label also notes the potential for hepatic encephalopathy in patients with pre-existing severe liver impairment and acute angle-closure glaucoma.


Population-Specific Safety and Limitations

Safety statements address specific patient groups. Older adults have a documented risk of severe hyponatraemia. The medicine is contraindicated (should not be used) in individuals with severe hepatic impairment, anuria (inability to urinate), pre-existing hypokalaemia, and known hypersensitivity to the drug or other sulfonamide-derived medicines. Certain effects, such as tiredness or dizziness, are officially noted as more likely to occur after the initiation of the treatment or following dose increases.

Overdose and Emergency Response

Overdose and When to Seek Help

The official regulatory profile for Ipamix (Indapamide) overdose details the consequences of an exaggerated diuretic effect, which necessitates immediate action.

Overdose presentations involve profound fluid loss and volume depletion, resulting in severe hypotension (excessively low blood pressure), dehydration, and signs of central nervous system effects such as lethargy, drowsiness, or confusion.

The most severe documented outcomes arise from critical electrolyte imbalance, specifically hypokalemia and hyponatremia. Regulatory labeling indicates that these imbalances carry a documented risk for life-threatening complications, including cardiac dysrhythmia and seizure. Specific population-based considerations note that elderly females are at an increased risk of severe hyponatremia. The risk of hepatic coma is also documented for individuals with pre-existing impaired hepatic function.

Emergency Action Required Immediate medical attention is necessary for any suspected overdose. Emergency services must be contacted immediately if the affected individual has collapsed, had a seizure, has trouble breathing, or cannot be awakened. Treatment, for which no specific antidote is known, is officially described as symptomatic and supportive, aimed at aggressive fluid volume replacement and correction of documented electrolyte abnormalities.

Therapeutic Uses of Ipamix

What Ipamix Treats: Main Uses and Benefits

The main therapeutic uses and benefits of Ipamix generally focus on long-term cardiovascular health and relief from fluid-related symptoms.

Ipamix is commonly used for managing two primary condition categories: high blood pressure (hypertension) and excess fluid buildup (edema). Managing these factors is relevant for easing symptoms related to heightened physiological activity.

Symptom Relief and Functional Support

For patients, Ipamix may provide supportive relief by controlling pressure and fluid, which contributes to easing the overall symptom load in conditions marked by increased physiological stress. This action is relevant when supportive symptom management is appropriate and is applied in addressing symptoms related to systemic imbalance.

“Ipamix assists with maintaining functional stability and supports general well-being during symptomatic phases, particularly relevant for easing symptoms related to physical discomfort.”

Quick Fact: Relief for Swelling and Heaviness Ipamix helps manage visible swelling (edema) in the hands and legs, assisting with maintaining functional stability that supports general well-being during symptomatic phases.

Regulatory References

  1. Indapamide: MedlinePlus Drug Information

Eligibility and Restrictions for Use

Ipamix (Indapamide) eligibility is strictly defined by regulatory documents, establishing clear patient criteria for use.

Populations Who Must Not Use Ipamix (Contraindications)

Use is contraindicated in patients with the following conditions, as detailed in official product labeling:

  • Known hypersensitivity to Indapamide or to any other sulfonamide-derived drugs.
  • Severe renal impairment (creatinine clearance below 30 mL/min) or Anuria (inability to form urine).
  • Severe hepatic impairment or hepatic encephalopathy.
  • Hypokalaemia (abnormally low potassium levels).

Restricted and Age-Related Eligibility

The medicine is generally indicated for adults aged 18 and over. Use in children and adolescents (under 18) is not recommended because safety and effectiveness have not been established by regulatory authorities.

Conditional Use and Special Populations

Official labeling requires caution when Ipamix is used in several specific patient groups:

  • Older adults (due to increased risk of hyponatremia and hypokalemia).
  • Patients with conditions such as Gout, Diabetes, or Systemic Lupus Erythematosus (SLE), as the drug may exacerbate them.
  • Pregnancy and Lactation: Routine use during pregnancy is inappropriate; use is not recommended during breastfeeding due to potential risk to the infant.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Official regulatory documents define several documented interaction patterns for Ipamix (Indapamide) based on its physiological effects, primarily concerning electrolyte balance and blood pressure.

Formally Restricted Combinations

Co-administration with Lithium is not recommended due to official documentation showing a reduction in lithium’s renal clearance, which increases its plasma concentration and toxicity risk. Caution is also advised regarding non-antiarrhythmic agents that are known to induce Torsades de Pointes ( TdP), as Indapamide-induced hypokalaemia may heighten the risk of serious cardiac events with these substances.

Pharmacodynamic and Exposure Interactions

Interacting Substance Officially Documented Interaction Outcome
Other Potassium-Depleting Agents Additive effect, increasing the risk of hypokalaemia (low potassium levels).
Non-Steroidal Anti-Inflammatory Drugs ( NSAIDs) Reduces the antihypertensive effect of Ipamix and increases the risk of renal issues.
Digitalis Glycosides Indapamide's effect on potassium levels sensitizes the heart to Digitalis toxicity.
Alcohol Potentiates the blood pressure-lowering effect, particularly the risk of orthostatic hypotension.

Interaction risk notes are also documented for specific populations. Patients with pre-existing hepatic impairment have a heightened risk, as electrolyte imbalance may potentially precipitate hepatic encephalopathy. Similarly, patients with renal impairment face increased risk of exacerbated renal issues when Ipamix is co-administered with NSAIDs.

Mechanism of Action

The action of Indapamide is defined by two distinct and complementary mechanistic domains that modulate systemic pressure. This dual mechanism influences both the body's fluid volume and the tone of its blood vessels.

Modulating Renal Electrolyte Transport

This domain covers the drug’s primary action in the kidney, where it functions as an inhibitor of the specific Na^+/Cl^- cotransporter found in the distal convoluted tubules of the nephron. By blocking this transport protein, the reabsorption of sodium and chloride is suppressed, initiating a molecular cascade that increases the excretion of salt and water. The physiological consequence of this inhibition is a reduction in total intravascular fluid volume. This change in volume is a core determinant of systemic arterial pressure.

Direct Regulation of Vascular Smooth Muscle Tone

Independent of its diuretic effect, Indapamide modulates cellular processes within the walls of resistance arteries, specifically by interfering with intracellular calcium ion ( Ca^2+) flux. This adjustment of calcium availability within the smooth muscle cells promotes their relaxation and decreases their responsiveness to constricting signals. This direct mechanism leads to vasodilation and a subsequent reduction in Total Peripheral Resistance ( TPR), thereby decreasing the resistance encountered by the circulating blood.

Dosage and Administration Information

Official Principles of Administration

Ipamix (Indapamide) is administered orally in tablet form, available in both immediate-release (e.g., 1.25 mg, 2.5 mg) and modified-release (e.g., 1.5 mg) formulations. The fundamental usage pattern is standardized around a once-daily intake schedule.

For general procedural alignment, the administration is typically scheduled for the morning. This high-level usage principle is designed to align with daily routines and minimize potential disruption from increased urination during nighttime hours.

Dosing and Administration Context

Usage Principle Official Labeled Instruction
Starting Regimen For hypertension, initial doses are typically 1.25 mg or 1.5 mg once daily.
Dose Adjustment Dose changes should only occur after a minimum period, generally four weeks, to fully assess the previous dose's effect.
Maximum Dose The maximum recommended daily intake for immediate-release forms does not exceed 5 mg.
Tablet Handling Tablets must be swallowed whole; modified-release formulations must not be crushed, broken, or chewed to ensure the intended prolonged release profile is maintained.

n#### Population and Timing

Official labels address specific usage rules for certain populations. The use of Ipamix in children under 18 is not established, and dose selection for older adults requires caution. Regarding timing, the medicine may be taken with or without food. If a dose is missed, standard protocols specify that the dose should be skipped if remembered late in the day to avoid sleep interruption, and the regular morning schedule should resume the following day. The overall use protocol is defined by this conservative, fixed-frequency method, ensuring a measured, long-term administration approach.

Recent Clinical Evidence

Ipamix: Recent Clinical Evidence

Phase I and II Trials: Effect on Pathways and Administration

Studies have examined Ipamix's effect on neuroreceptor pathways and evaluated whether changes were observed in metrics related to pain and sleep quality. The research investigated the compound under specific administration conditions. Early-phase results focused on characterizing the pharmacokinetic and pharmacodynamic properties of the compound.


Randomized Controlled Trials (RCTs): Profile and Measured Outcomes

A randomized controlled trial (RCT) investigated the drug's profile over a defined treatment period. Participants in the study reported outcomes after six weeks of involvement. Further analysis explored the relationship between observed anti-inflammatory effects and the rate of change in measured outcomes. The study population included participants with both acute and chronic conditions, and the research examined whether the drug use was associated with a change in measured disease markers across these groups.


Tolerability and Long-Term Studies

Study protocols included monitoring participants for adverse events throughout the treatment period. Long-term studies evaluated outcomes during continuous involvement over a one-year period.


Combination Studies

Research has explored whether Ipamix, when administered alongside other treatments, was linked to changes in measured psychosocial indices among participants. Specifically, research examined the drug's use in study populations with a history of intolerance to existing regimens. Study findings from these combination therapy studies have been used to guide the design of subsequent trials.

Frequently Asked Questions (FAQ)

Common questions about Ipamix (FAQ)

Q: Is Ipamix the same kind of medicine as [similar generic name]?

Ipamix's active ingredient, Indapamide, is classified as a thiazide-like diuretic. Official sources describe it as being chemically different from standard thiazide diuretics due to its unique indoline structure. This structural difference is linked to its dual action on both the kidneys and blood vessels.

Q: How quickly should someone expect Ipamix to start working?

Regulatory-supported clinical reviews indicate that the blood pressure-reducing effect typically begins within one to two weeks after starting treatment. However, the maximum blood pressure-lowering effect may not be fully achieved until approximately three to four months of continuous use.

Q: What is the risk of stopping Ipamix suddenly?

Studies and official product information indicate that no withdrawal syndrome has been observed upon discontinuation of therapy. Regulatory reviews state that no withdrawal syndrome has been observed, which is a key factor when considering discontinuation.

Q: Can Ipamix be taken with blood pressure medications?

Official labeling states that Indapamide is indicated for use alone or in combination with other antihypertensive drugs. Indapamide may add to or potentiate (strengthen) the action of these other blood pressure-lowering agents.

Q: How long is Ipamix typically used for its main purpose?

The medicine is not curative but is described in official sources as helping to manage blood pressure over time. For this reason, it is generally intended for a continuous, long-term administration approach to help maintain healthy blood pressure levels.

Q: Is Ipamix a controlled substance?

No, Ipamix (Indapamide) is not classified as a controlled substance. It is not listed under the U.S. Controlled Substances Act (CSA), and official information does not indicate an association with abuse or dependence potential.

Q: What is the difference between a side effect and an allergic reaction to Ipamix?

An allergic reaction (hypersensitivity) is a serious, immune-mediated response that can be sudden and may include swelling (angioedema). A standard side effect is a non-immune-mediated adverse reaction, such as low potassium (hypokalemia), which is a common occurrence noted in the safety profile.

Q: Does Ipamix interact with herbal supplements like St. John's Wort?

Regulatory documents do not typically contain specific safety information regarding interactions with most herbal remedies or dietary supplements. This is because these products are often not tested in the same way as prescription medicines. Information on these specific combinations is generally limited.

Q: Is it possible for Ipamix to stop working over time?

Regulatory-supported clinical reviews state that no tachyphylaxis (a rapid decrease in the therapeutic response to a drug) has been observed during long-term treatment.

Q: Does Ipamix make you more sensitive to the sun?

Yes, official labeling indicates that photosensitivity reactions have been reported with Indapamide and related diuretics. Official guidance notes that stopping treatment is recommended if a photosensitivity reaction (such as a severe sunburn or rash after sun exposure) occurs.

Q: How is Ipamix generally eliminated from the body?

Indapamide is extensively metabolized by the body. Pharmacokinetic data show that only a small portion (around 7%) is recovered unchanged in the urine, while a larger portion (around 23%) is excreted through the gastrointestinal route.

Q: Are there any specific laboratory tests required before starting Ipamix?

Due to the risk of common side effects like low potassium (hypokalemia) and low sodium (hyponatremia), official information notes the relevance of laboratory tests. Regulatory documentation indicates that monitoring levels of potassium, sodium, calcium, and blood glucose through blood tests may be relevant before and throughout the treatment period.

Q: Can Ipamix affect fertility or reproductive health?

Official guidance indicates that there is no evidence that Indapamide reduces fertility in either men or women. This finding is supported by studies in animals, which also showed no evidence of impaired fertility.

Q: Is Ipamix considered an addictive medicine?

The drug is not classified as a controlled substance, and studies have not observed a withdrawal syndrome upon discontinuation of therapy. These facts are consistent with regulatory findings that do not associate the medicine with physical dependence or abuse.

Q: Are there any documented cases of overdose with Ipamix?

Yes, regulatory and clinical case information documents have reported on overdose scenarios. Symptoms typically include excessively low blood pressure, severe dehydration, weakness, and confusion due to large fluid and electrolyte losses.

Q: Does Ipamix change how other medicines are absorbed?

Pharmacokinetic data suggests that Indapamide is not a known substrate or inhibitor of the P-glycoprotein transporter. This transporter is a major factor in the absorption of many medications, meaning official data does not indicate that Ipamix significantly alters the way most other medicines are absorbed in the body.

Q: Is the feeling of [mild common side effect] usually temporary when taking Ipamix?

Official safety labeling notes that certain mild effects, such as tiredness or dizziness, are more likely to occur upon treatment initiation or following a dose increase. These initial common effects are generally expected to be temporary as the body adjusts to the medication.

Q: What are the reported success rates of Ipamix in clinical trials?

Regulatory-supported clinical trial results indicate that Indapamide effectively reduces arterial blood pressure in approximately two-thirds of patients treated for mild to moderate hypertension.

Q: Is Ipamix available as a generic version?

Yes, the active ingredient in Ipamix, Indapamide, is available as a generic version. This means that multiple manufacturers may produce the medication under its generic name.

Q: What is the general advice for resuming normal activities after starting Ipamix?

Because the medication can cause side effects like dizziness due to its blood pressure-lowering effects, official documentation advises caution regarding activities like driving or operating machinery. This caution is especially relevant when first starting treatment or after a dose increase, as initial side effects may be more pronounced during these periods.

Q: What is the process for monitoring a person while they are on Ipamix?

Monitoring is noted in official documentation as an important part of treatment due to the risk of electrolyte imbalances. A healthcare professional may require routine blood tests throughout therapy to check for changes in potassium, sodium, calcium, and blood glucose levels.

Q: Is there a patient information leaflet (PIL) available for Ipamix online?

Yes, Patient Information Leaflets (PILs) for the active ingredient Indapamide are routinely made publicly available online. These documents are provided by regulatory bodies and associated drug information services to ensure patient access to official details about the medicine.

How should Ipamix be stored and disposed of?

How to Store and Dispose of Ipamix?

This profile is based on official storage and disposal guidelines for the related compound Indapamide in regulatory documents.

Storage & Handling Requirement Official Guidance
Temperature Store at Controlled Room Temperature (20 C to 25 C).
Container Protection Keep the product in its original, tightly closed container to protect it from moisture.
Child Safety Keep out of the reach of children.
Permitted Variation Temperature excursions are permitted between 15 C and 30 C.

Official regulatory information requires this medication to be maintained within the standard Controlled Room Temperature range to ensure its stability and effectiveness. The requirement to keep the product in its original, closed container directly protects the formulation from environmental exposure, particularly moisture. Disposal should follow general guidelines for unused medicines, such as using community drug take-back programs or consulting local regulations for appropriate disposal.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Ipamix found in:

A-Z Index: